- New
- Decision support
- promising evidence
- 4 min · 9 sources
- Published Sep 9, 2026
Is melatonin safe to take every night, and how long does it stay in your system?
The short answer
Melatonin is generally safe for nightly use for a few weeks in healthy adults, and immediate-release melatonin usually clears by morning while prolonged-release products last longer overnight.
Melatonin feels simple because it is sold beside vitamins. The harder question is whether nightly use is solving the right sleep problem or just becoming a habit.
In short
- Melatonin is better suited to circadian timing problems, such as delayed sleep timing or jet lag, than to ordinary chronic insomnia.
- Nightly use for a few weeks is generally low risk for healthy adults, but long term continuous safety data are thinner than the marketing implies.
- Immediate release melatonin is usually mostly cleared by morning, but higher doses and prolonged release products increase the chance of next day sleepiness.
- The product label may not tell you exactly what you are taking, since tested supplements have shown large variation in actual melatonin content.
Melatonin Every Night
The direct answer
If you are a healthy adult using a low dose of melatonin every night for a short stretch, it is usually a reasonable risk. That does not mean it is a good default forever. Melatonin works best when the problem is timing: your internal sleep schedule is shifted later than your real life requires, or you are crossing time zones. It is less convincing as a nightly fix for chronic insomnia, where the American Academy of Sleep Medicine suggests clinicians not use melatonin for sleep onset or sleep maintenance insomnia in adults because the evidence is weak and the average benefit is small.3
How long it stays in your system depends on the formulation. Immediate release melatonin rises and falls quickly, with systematic pharmacokinetic reviews generally finding a short elimination half life, often in the range of about 20 to 60 minutes. Prolonged release products are designed to keep levels elevated longer, so they can affect the second half of the night and, in some people, the next morning.1
What the evidence actually shows
The best supported role for melatonin is not as a sedative. It is a circadian signal. Taken at the right time, it can shift the sleep wake rhythm earlier. That is why clinical guidance has been more favorable for delayed sleep wake phase disorder and jet lag than for broad adult insomnia.6
For chronic insomnia, the evidence is less impressive. The 2017 AASM pharmacologic guideline reviewed adult insomnia trials and issued a weak recommendation against melatonin for sleep onset or sleep maintenance insomnia. That does not mean melatonin never helps anyone. It means that, across the evidence base, the benefits were not strong enough or consistent enough to make it a recommended insomnia treatment.3
Safety looks better in the short term than in the long term. A review of adverse events found that reported side effects are usually mild, such as sleepiness, headache, dizziness, or nausea, but also emphasized that long term randomized evidence is scarce. That matters because many people take melatonin as if it has the long term safety record of a basic nutrient. It does not.4
There is also a newer caution signal, not a conclusion. A 2025 preliminary American Heart Association report described an observational association between long term melatonin use for insomnia and higher rates of heart failure outcomes and death over five years. Because it was observational and presented as preliminary research, it cannot prove melatonin caused those outcomes. It does reinforce the practical point: nightly use for years should not be treated as automatically benign.7
What changes the answer
The first condition is the sleep problem. If you fall asleep at 2 a.m. but sleep well once asleep, melatonin may be a timing tool. If you wake repeatedly at 3 a.m., worry in bed, drink caffeine late, or have untreated sleep apnea symptoms, melatonin is unlikely to be the central fix. For chronic insomnia, cognitive behavioral therapy for insomnia has a stronger role than supplementing a hormone signal.3
The second condition is dose. More is not automatically better. Many adults start with 0.5 to 1 mg, taken 1 to 2 hours before the desired bedtime when the goal is circadian shifting. For a simple sleep onset experiment, some people use 1 to 3 mg closer to bedtime. Higher doses are more likely to cause vivid dreams, morning grogginess, headache, or a heavy feeling the next day. They also push blood levels above the range needed for a timing signal.14
The third condition is formulation. Immediate release is the better match when the problem is falling asleep or shifting bedtime earlier. Prolonged release is meant to last longer, and some 2 mg prolonged release products have been studied for older adults with insomnia symptoms. That longer exposure can be useful for sleep maintenance in selected people, but it also makes the “how long does it stay in your system?” answer less clean.18
Age and situation matter. Older adults may have lower nighttime melatonin secretion, which is one reason prolonged release melatonin has been studied in people over 55. Children are a separate decision. Pediatric use should involve a clinician, especially for neurodevelopmental conditions, puberty concerns, accidental ingestion risk, and dose selection. CDC surveillance found 260,435 pediatric melatonin ingestions reported to poison control centers from 2012 through 2021, with a 530 percent increase over that period.9
Pregnancy, breastfeeding, seizure disorders, autoimmune conditions, anticoagulant use, sedatives, alcohol use, and complex medical histories also change the safety calculation. In those cases, nightly melatonin belongs in a clinician conversation, not in a self directed routine.2
The confound that does not matter as much as people think
The common fear is that melatonin is addictive. Dependence is not the main concern. Unlike many hypnotic drugs, melatonin is not generally associated with classic dependence or withdrawal. The better concern is behavioral reliance: taking it nightly while ignoring the reason sleep is off.2
The other overlooked issue is product quality. In one analysis of 31 melatonin supplements, the measured melatonin content varied widely from the label amount, and serotonin was detected in some products. That means a person who thinks they are taking 1 mg may not be taking 1 mg.5
The decision to make today
Use melatonin as a time limited experiment, not an open ended nightly subscription. If you are an adult with no major medical complications, choose an independently tested immediate release product, start with 0.5 to 1 mg, and take it at the same time nightly for 1 to 2 weeks if your problem is a delayed sleep schedule. If it helps, keep the dose low and reassess after 2 to 4 weeks. If you still need it every night after a month, or if your sleep problem is frequent awakenings, snoring, restless legs, anxiety, pain, or daytime sleepiness, the better move is to evaluate the sleep problem rather than raise the dose.
What this piece does not address
-
Does not establish long term nightly melatonin as risk free.
Long term randomized safety data are limited, and newer observational cardiovascular signals are not yet causal but are worth respecting.
-
Does not cover individualized pediatric dosing.
Children have different risk considerations, and accidental ingestion has become a public health concern.
-
Does not replace evaluation for sleep apnea, restless legs, mood disorders, pain, or medication related insomnia.
Melatonin can shift timing, but it will not correct many common drivers of poor sleep.
-
Does not apply cleanly to pregnancy, breastfeeding, seizure disorders, or complex medication regimens.
Those situations need clinician guidance before nightly use.
Common questions
How long does melatonin stay in your system?
Is it safe to take melatonin every night?
Can you become dependent on melatonin?
What is the best time to take melatonin?
Is a higher melatonin dose better?
Sources
Sources
- 1. Clinical pharmacokinetics of melatonin: a systematic review (2015)
- 2. Melatonin: What You Need To Know (2026)
- 3. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults (2017) ↑
- 4. Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review (2019)
- 5. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content (2017) ↑
- 6. Melatonin for the Treatment of Intrinsic Circadian Rhythm Sleep Wake Disorders (2015)
- 7. Long-term use of melatonin supplements to support sleep may have negative health effects (2025)
- 8. Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study (2011)
- 9. Pediatric Melatonin Ingestions, United States, 2012 to 2021 (2022)
- [1] web Pharmacokinetic half life and formulation distinction
- [2] regulatory Public safety cautions and short term use framing
- [3] web Adult chronic insomnia guideline recommendation
- [4] web Adverse events and long term evidence limitation
- [5] web Quality control and label mismatch confound
- [6] web Circadian rhythm indication distinction
- [7] web Recent preliminary long term safety signal
- [8] web Prolonged release older adult evidence context
- [9] regulatory Pediatric ingestion surveillance